Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.
about
Dynamic knee joint function in children with juvenile idiopathic arthritis (JIA).Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control study.Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanerceptCourse of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPIC.Etanercept: a review of its use in autoimmune inflammatory diseases.The humanistic and economic burden of juvenile idiopathic arthritis in the era of biologic medication.Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance.[Evidence of treatment of chronic inflammation in childhood and adolescence with biologics].Health-related quality of life in an inception cohort of children with Juvenile Idiopathic Arthritis: A longitudinal analysis.Oral health and quality of life of children and adolescents with juvenile idiopathic arthritis according to their caregivers' perceptions.Influence of etanercept on leptin and ghrelin secretion in children with juvenile idiopathic arthritis.Serious Adverse Events Associated with Anti-Tumor Necrosis Factor Alpha Agents in Pediatric-Onset Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis in A Real-Life Setting.Cyclic Tensile Strain Reduces TNF-α Induced Expression of MMP-13 by Condylar Temporomandibular Joint Cells.The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON).
P2860
Q35232922-B76B5DE0-0F6F-43D9-8286-C1FEE95DFCB6Q36538046-3B5F7965-FFE6-4F46-B016-7AE5254BFDB7Q37518319-5DA2885C-B5A6-4A08-A7C2-23F73BB80002Q37728461-E0A8627C-C858-4C95-993C-CBBFBE2EB4FFQ38230740-0E74ECD0-E2F9-41DC-B686-A6B9D8DD03F7Q38421293-D97580F9-8AF6-4628-8B68-C2D7976F4A9FQ38817268-A588EA3A-B689-46B8-8053-1235BE143971Q40179129-63A7BF35-5ECA-4EF6-B016-D5643BC296B8Q40284612-4571481F-FF27-4DDB-A9B3-26D7B669EFC4Q41500942-2D65967D-91C9-48EC-93FE-BA7D6B70FD3BQ41813478-C7772F00-903A-47D9-A74F-DA167388D016Q47198925-4F244879-7295-467E-A2D4-32F1C7235CB6Q51518094-62AD2FCD-F739-4ABE-92B4-8F2262A99A20Q55192377-819BFBE5-6C21-4515-9C09-E9AEC987E38B
P2860
Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Improvement in health-related ...... of treatment with etanercept.
@en
type
label
Improvement in health-related ...... of treatment with etanercept.
@en
prefLabel
Improvement in health-related ...... of treatment with etanercept.
@en
P2093
P2860
P356
P1476
Improvement in health-related ...... of treatment with etanercept.
@en
P2093
Andreas Urban
Angelika Thon
Gerd Ganser
Gerd Horneff
Jens Klotsche
Kirsten Minden
P2860
P304
P356
10.1002/ACR.22112
P577
2014-02-01T00:00:00Z